|
|
|
Diaclone ELISpot/Fluorospot is a highly specific immunoassay for the analysis of cytokine and other soluble molecule production and secretion from T-cells at a single cell level in conditions closely comparable to the in-vivo environment with minimal cell manipulation.
Extensive antibody range across different species with high specificity and affinity for a number of different cytokines and soluble molecules in different formats
· Single/dual analyte enzymatic detection systems
· Dual analyte fluorescent detection systems
· Matched antibody pairs, a great tool for developing research.
With the benefits of specific, sensitive, accurate and reliable measurement of cytokines and soluble molecules from a very low ratio of cells coupled to the diversity of the product range Diaclone ELISpot is a clear choice to
Fast Track Your Research…..
| Products |
|
IFNg / IL-10 Dual Fluorospot 1x96, 5x96, 10x96, 15x96, 20x96 tests
Dual Human IFN-g / IL-10 Fluorospot
874.012.001, 874.012.005, 874.012.010, 874.012.015, 874.012.020 |
|
IFNg / IL-2 Dual Fluorospot 1x96, 5x96, 10x96, 15x96, 20x96 tests
Dual Human IFNg / IL-2 Fluorospot
874.042.001, 874.042.005, 874.042.010, 874.042.015, 874.042.020 |
|
IFNg / IL-4 Dual Fluorospot 1x96, 5x96, 10x96, 15x96, 20x96 tests
Dual Human IFNg / IL-4 Fluorospot
874.002.001, 874.002.005, 874.002.010, 874.002.015, 874.002.020 |
|
IFNg / IL-5 Dual Fluorospot 1x96, 5x96, 10x96, 15x96, 20x96 tests
Dual Human IFNg / IL-5 Fluorospot
874.032.001, 874.032.005, 874.032.010, 874.032.015, 874.032.020 |
|
IFNg/GrB Dual Fluorospot 1x96, 5x96, 10x96, 15x96, 20x96 tests
Dual Human IFNg / Granzyme B Fluorospot
874.062.001, 874.062.005, 874.062.010, 874.062.015, 874.062.020 |
|
IL-10 / IL-2 Dual Fluorospot 1x96, 5x96, 10x96, 15x96, 20x96 tests
Dual Human IL-10 / IL-2 Fluorospot
874.052.001,874.052.005, 874.052.010, 874.052.015, 874.052.020 |
|
IL-10 / IL-4 Dual Fluorospot 1x96, 5x96, 10x96, 15x96, 20x96 tests
Dual Human IL-10 / IL-4 Fluorospot
874.022.001, 874.022.005, 874.022.010, 874.022.015, 874.022.020 |
|
|
|
|
|
